797 filings
Page 4 of 40
CORRESP
LEXX
Lexaria Bioscience Corp
4 May 23
Correspondence with SEC
12:00am
CORRESP
LEXX
Lexaria Bioscience Corp
4 May 23
Correspondence with SEC
12:00am
CORRESP
LEXX
Lexaria Bioscience Corp
3 May 23
Correspondence with SEC
12:00am
CORRESP
LEXX
Lexaria Bioscience Corp
3 May 23
Correspondence with SEC
12:00am
S-1/A
LEXX
Lexaria Bioscience Corp
IPO registration (amended)
28 Apr 23
4:28pm
10-Q
2023 Q2
LEXX
Lexaria Bioscience Corp
Quarterly report
14 Apr 23
12:44pm
UPLOAD
LEXX
Lexaria Bioscience Corp
7 Apr 23
Letter from SEC
12:00am
S-1
LEXX
Lexaria Bioscience Corp
IPO registration
3 Apr 23
5:26pm
DEF 14A
LEXX
Lexaria Bioscience Corp
Definitive proxy
22 Mar 23
8:03am
PRE 14A
LEXX
Lexaria Bioscience Corp
Preliminary proxy
10 Mar 23
1:33pm
8-K
LEXX
Lexaria Bioscience Corp
3 Mar 23
Lexaria’s DehydraTECH-CBD Diabetes Study Demonstrates Weight Loss, Improved Triglyceride and Cholesterol Levels
6:03am
4
Turkel Catherine C.
27 Feb 23
Lexaria Bioscience / CATHERINE C. TURKEL ownership change
10:52am
SC 13G/A
Invenomic Capital Management LP
10 Feb 23
Lexaria Bioscience / Invenomic Capital Management ownership change
4:06pm
8-K
LEXX
Lexaria Bioscience Corp
23 Jan 23
Regulation FD Disclosure
2:49pm
10-Q
2023 Q1
LEXX
Lexaria Bioscience Corp
Quarterly report
17 Jan 23
4:50pm
8-K
LEXX
Lexaria Bioscience Corp
17 Jan 23
Regulation FD Disclosure
6:01am
EFFECT
LEXX
Lexaria Bioscience Corp
30 Dec 22
Notice of effectiveness
12:15am
POS AM
LEXX
Lexaria Bioscience Corp
28 Dec 22
Prospectus update (post-effective amendment)
2:32pm
EFFECT
LEXX
Lexaria Bioscience Corp
23 Dec 22
Notice of effectiveness
12:15am